Evidence map›Paper›PMID 27076076›Full record

ArticleCell metabolism2016

The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome.

Baokun He, Kazunari Nohara, Noheon Park, Yong-Sung Park, Bobby Guillory, Zhaoyang Zhao, Jose M Garcia, Nobuya Koike, Cheng Chi Lee, Joseph S Takahashi and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 285 papers.

0numbers the graph read from it
0cells of the map it votes in
285citing papers in PubMed
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

285 citing papers in PubMed, 486 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Small Molecule Regulation of CLOCK:BMAL1 DNA Binding Activity.bioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Article
  20. Review

225 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Baokun HeDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Kazunari NoharaDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Noheon ParkDepartment of Neuroscience, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
Yong-Sung ParkDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Bobby GuilloryDivision of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research in Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, and Department of Medicine, and Molecular and Cell Biology, Dan L. Duncan Cancer Center, Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Zhaoyang ZhaoDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Jose M GarciaDivision of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research in Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, and Department of Medicine, and Molecular and Cell Biology, Dan L. Duncan Cancer Center, Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Nobuya KoikeDepartment of Physiology and Systems Bioscience, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Cheng Chi LeeDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Joseph S TakahashiDepartment of Neuroscience, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Seung-Hee YooDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Zheng ChenDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA. Electronic address: zheng.chen.1@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · USThe University of Texas Southwestern Medical Center · USKyoto Prefectural University of Medicine · JP

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
NIH Director's Pioneer AwardDP1OD000895 · OD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LEE, CHENG CHI · 2006 to 2010
$3.7M
CELL &MOLECULAR BIOLOGY OF AGINGT32AG000183 · NIA · BAYLOR COLLEGE OF MEDICINE · PI DONEHOWER, LAWRENCE A. · 1989 to 2015
$3.7M
Regulation and function of the circadian factor Period2R01GM114424 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YOO, SEUNG-HEE · 2015 to 2019
$1.6M
Role of Clock-Modulating Small Molecules Against AgingR01AG045828 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHEN, ZHENG · 2013 to 2017
$1.4M
The role of ghrelin and the ghrelin receptor GHSR1a in sarcopenia of agingR03AG040583 · NIA · BAYLOR COLLEGE OF MEDICINE · PI GARCIA, JOSE M. · 2011 to 2012
$157k
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic ObesityI01BX002807 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI GARCIA, JOSE M. · 2016 to 2025
–
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer-related caI01BX000507 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI GARCIA, JOSE M. · 2009 to 2013
–
The Role of Ghrelin in Cancer CachexiaI01CX000174 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI GARCIA, JOSE M. · 2009 to 2014
–
BLRD VA I01 BX000507BLRD VA I01 BX002807CSRD VA I01 CX000174NIA NIH HHS AG040583NIA NIH HHS R01 AG045828NIA NIH HHS R01AG045828NIA NIH HHS R03 AG040583NIA NIH HHS T32 AG000183NIA NIH HHS T32AG000183NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30-DK056338NIGMS NIH HHS R01 GM114424NIH HHS DP1 OD000895NIH HHS OD000895
6 · The paper itself

Abstract

Dysregulation of circadian rhythms is associated with metabolic dysfunction, yet it is unclear whether enhancing clock function can ameliorate metabolic disorders. In an unbiased chemical screen using fibroblasts expressing PER2::Luc, we identified Nobiletin (NOB), a natural polymethoxylated flavone, as a clock amplitude-enhancing small molecule. When administered to diet-induced obese (DIO) mice, NOB strongly counteracted metabolic syndrome and augmented energy expenditure and locomotor activity in a Clock gene-dependent manner. In db/db mutant mice, the clock is also required for the mitigating effects of NOB on metabolic disorders. In DIO mouse liver, NOB enhanced clock protein levels and elicited pronounced gene expression remodeling. We identified retinoid acid receptor-related orphan receptors as direct targets of NOB, revealing a pharmacological intervention that enhances circadian rhythms to combat metabolic disease via the circadian gene network.

Indexed as

AnimalsCircadian RhythmFlavonesGene Expression RegulationLiverMaleMetabolic SyndromeMiceMice, Inbred C57BLMice, ObeseNuclear Receptor Subfamily 1, Group F, Member 1FlavonesnobiletinNuclear Receptor Subfamily 1, Group F, Member 1Rora protein, mousecircadian clockclock amplitude-enhancing small moleculemetabolic syndromenatural flavonoidNobiletinretinoid acid receptor-related orphan receptors (RORs)

Identifiers

PMID27076076
PMCPMC4832569
OpenAlexW2342036008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.